共 16 条
[1]
Flach A.J., Cyclo-oxygenase inhibitors in ophthalmology, Surv. Ophthalmol., 36, pp. 259-284, (1992)
[2]
Cronin M.E., Wortmann R.L., Nonsteroidal antiinflammatory drugs (NSAIDs)
[3]
common chemical and clinical characteristics, Intl J. Dermatol., 23, pp. 411-413
[4]
Riegel M., Ellis P.P., High performance liquid Chromatographie assay for antiinflammatory drugs in the aqueous humor of the eye, J. Chromatog., 654, pp. 140-145, (1994)
[5]
Gibaldi M., Perrier D., Pharmacokinetics, (1982)
[6]
VAN Haeringen N.J., Oosterhuis J.A., van Delft J.L., Glasius E., Noach E.L., A comparison of the effects of non-steroidal compounds on the disruption of the blood-aqueous barrier, Exp. Eve Res., 35, pp. 271-277, (1982)
[7]
Sallman A., Chemical aspects of diclofenac, pp. 296-301, (1976)
[8]
Risdall P.C., Adams S.S., Crampton E.L., Marchant B., The disposition and metabolism of flurbiprofen in several species including man, Xenobiotica, 8, pp. 691-704, (1978)
[9]
Goa K.L., Chrisp P., Ocular diclofenac, Drugs Aging, 2, pp. 473-486, (1992)
[10]
Tang-Liu D.D., Liu S.S., Weinkam R.J., Ocular and systemic bioavailability of ophthalmic flurbiprofen, J. Pharmacokinet. Biopharm., 12, pp. 611-626, (1984)